Anticoagulant therapy: through a glass darkly
Hampton, J.W.
American Family Physician 9(2): 100-104
1974
ISSN/ISBN: 0002-838X PMID: 4810867 Document Number: 72887
Document emailed within 1 workday
Related Documents
Parker, G. 2006: Through a glass darkly: the disutility of the DSM nosology of depressive disorders Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 51(14): 879-886Whiteside, A.; Barnett, T.; George, G.; Van Niekerk, A.A. 2003: Through a glass, darkly: data and uncertainty in the AIDS debate Developing World Bioethics 3(1): 49-76
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Kosaka, T.; Nagase, M.; Suzuki, Y.; Kobayashi, N. 1980: Anticoagulant therapy in combination with pulse therapy--about 12 nephritic patients with nephrotic syndrome-- Nihon Jinzo Gakkai Shi 22(8): 1095-1111
Römer, T. 1994: Hysteroscopic therapy of recurrent hemorrhage in long-term anticoagulant therapy Zentralblatt für Gynakologie 116(12): 695-696
Nemeth, L. 2001: Use of novel glass compositions in preparing dental glass pillars and support pillars, and method for producing the glass pillars Official Gazette of the United States Patent and Trademark Office Patents 1246(1)
Carroll, W.E.; Jackson, R.D. 1999: Modified anticoagulant therapy factor and international normalized ratio in patients in an unstable coagulation state with respect to warfarin therapy Research Communications in Molecular Pathology and Pharmacology 105(3): 262-270
Lechner, K.; Korninger, C.; Kyrle, P.; Geissler, K.; Niessner, H.; Pabinger, I.; Panzer, S.; Gössinger, H.; Bettelheim, P.; Hinterberger, W. 1987: Oral anticoagulant therapy--renaissance of an old therapy? Wiener Klinische Wochenschrift 99(7): 203-210
Holcenberg, J.S.; Veltkamp, J.J. 1970: Drug therapy. V. Oral anticoagulant therapy Northwest Medicine 69(6): 421-424
Lencioni, E.; Franchi, G.; Reghini, A.; Pezzuoli, G. 1983: Devices for use in pharmaceutical filling machines to reduce the presence of particles glass in glass ampules Bollettino Chimico Farmaceutico 122(1): 10-19
Schröder, H.J. 1973: Ileus during anticoagulant therapy Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 44(7): 329-332
Glee, E. 2011: How to look after patients on anticoagulant therapy Nursing Times 107(3): 21
Heene, D.L. 1977: Rebound following anticoagulant therapy Deutsche Medizinische Wochenschrift 102(30): 1106-1107
Sellers, E.M.; Koch-Weser, J. 1972: Oral anticoagulant therapy Canadian Medical Association Journal 106(4): 302 Passim
Jørsing, K. 1992: Psoriasis and anticoagulant therapy Ugeskrift for Laeger 154(35): 2373-2374
Gross, H.; Hasson, J.; Solomon, S. 1971: Anticoagulant therapy: a critique American Family Physician 3(6): 87-91
Uchiyama, S. 1993: Anticoagulant therapy in stroke Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 458-462
Straub, P.W. 1978: What is ensured in anticoagulant therapy? Zfa. Zeitschrift für Allgemeinmedizin 54(9): 487-495
Suwan-Apichon, O.; Ratanapakorn, T.; Panjaphongse, R.; Sinawat, S.; Sanguansak, T.; Yospaiboon, Y. 2010: 2.5% and 10% phenylephrine for mydriasis in diabetic patients with darkly pigmented irides Journal of the Medical Association of Thailand 93(4): 467-473
Prabhu, N.T.; Munshi, A.K.; Shetty, T.R. 1997: Marginal ridge fracture resistance, microleakage and pulpal response to glass ionomer/glass cermet partial tunnel restorations Journal of Clinical Pediatric Dentistry 21(3): 241-246